| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Small molecule |
| Molecule Category: | UNKNOWN |
| UNII: | F13K378W4L |
| InChI Key | HSQAARMBHJCUOK-UHFFFAOYSA-N |
|---|---|
| Smile | |
| InChI |
|
| Property Name | Value |
|---|---|
| Molecular Formula | C24H35ClN2O2 |
| Molecular Weight | 419.01 |
| AlogP | 4.19 |
| Hydrogen Bond Acceptor | 3.0 |
| Hydrogen Bond Donor | 3.0 |
| Number of Rotational Bond | 10.0 |
| Polar Surface Area | 61.36 |
| Molecular species | BASE |
| Aromatic Rings | 1.0 |
| Heavy Atoms | 29.0 |
| Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
|---|---|---|---|---|---|---|
|
Ion channel
Ligand-gated ion channel
P2X receptor
|
- | 10 | - | - | - |
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Arthritis, Rheumatoid | 2 | D001172 | ClinicalTrials |
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL3545108 |
| DrugBank | DB12594 |
| FDA SRS | F13K378W4L |
| Guide to Pharmacology | 7826 |
| SureChEMBL | SCHEMBL4126642 |
| ZINC | ZINC000034356159 |